Partner Content Partner Content Exclusive interview with Novartis industry leader, Maxime Ga... Exclusive interview with Novartis industry leader
Partner Content Partner Content Regulatory and Policy Keynote Sessions to be Delivered at th... Regulatory and Policy Keynote Sessions to be Delivered
Partner Content Partner Content Exclusive interview with AstraZeneca ahead of upcoming Weara... Wearable Injectors & Connected Devices
Partner Content Partner Content Department for International Trade to present at Wearable In... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content AstraZeneca to lead a workshop during the Wearable Injectors... Wearable Injectors and Connected Devices Conference
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
